Morningstar Investment Services LLC Amgen Inc Transaction History

Morningstar Investment Services LLC

$9.8 Billion
Q3 2024

A detailed history of Morningstar Investment Services LLC transactions in Amgen Inc stock. As of the latest transaction made, Morningstar Investment Services LLC holds 107,604 shares of AMGN stock, worth $29.4 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

107,604

Previous 107,991 0.36%

Holding current value

$29.4 Million

Previous $33.9 Million 2.49%

% of portfolio

0.35%

Previous 0.37%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$309.38 - $337.38 $119,730 - $130,566	-387 Reduced 0.36%	107,604 $34.7 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $402,007 - $488,544	-1,530 Reduced 1.4%	107,991 $33.9 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $34 Million - $41.1 Million	-126,505 Reduced 53.6%	109,521 $31.4 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $29.6 Million - $33.4 Million	115,879 Added 96.45%	236,026 $68.1 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $101,016 - $125,414	-462 Reduced 0.38%	120,147 $32.5 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $164,345 - $194,334	-767 Reduced 0.63%	120,609 $26.7 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $27.4 Million - $33.4 Million	121,376 New	121,376 $29.3 Million
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $321,329 - $408,287	1,403 Added 1.21%	117,705 $31 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $1.09 Million - $1.23 Million	4,843 Added 4.35%	116,302 $31 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $1.26 Million - $1.4 Million	5,445 Added 5.14%	111,459 $27.3 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $572,733 - $633,592	2,612 Added 2.53%	106,014 $25.7 Million
Q4 2021 Feb 01, 2022	SELL	$198.88 - $227.6 $117,736 - $134,739	-592 Reduced 0.57%	103,402 $23.3 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $25,047 - $29,346	118 Added 0.11%	103,994 $22.3 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $171,214 - $189,949	-733 Reduced 0.7%	103,876 $25.2 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $1.09 Million - $1.27 Million	-4,904 Reduced 4.48%	104,609 $26.1 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $1.37 Million - $1.64 Million	-6,352 Reduced 5.48%	109,513 $25.2 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $1.71 Million - $1.9 Million	-7,298 Reduced 5.93%	115,865 $28.8 Million
Q2 2020 Jul 30, 2020	SELL	$197.81 - $242.74 $862,055 - $1.06 Million	-4,358 Reduced 3.42%	123,163 $28.5 Million
Q1 2020 May 04, 2020	BUY	$182.24 - $241.7 $589,728 - $782,141	3,236 Added 2.6%	127,521 $26.6 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $112,390 - $144,460	594 Added 0.48%	124,285 $29.9 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $166,971 - $200,066	-959 Reduced 0.77%	123,691 $24 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $159,365 - $186,811	956 Added 0.77%	124,650 $23 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $11.8 Million - $13.3 Million	-65,251 Reduced 34.53%	123,694 $23.5 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $18.3 Million - $21.3 Million	-102,346 Reduced 35.14%	188,945 $36.8 Million
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $21 Million - $23.7 Million	-113,491 Reduced 28.04%	291,291 $60.4 Million
Q2 2018 Aug 03, 2018	SELL	$166.05 - $186.51 $7.91 Million - $8.88 Million	-47,622 Reduced 10.53%	404,782 $74.7 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $8.66 Million - $10.1 Million	-51,084 Reduced 10.15%	452,404 $77.1 Million
Q4 2017 Feb 08, 2018	SELL	$168.79 - $188.59 $2.79 Million - $3.11 Million	-16,514 Reduced 3.18%	503,488 $87.6 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $87 Million - $99.3 Million	520,002	520,002 $97 Million

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

405M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morningstar Investment Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morningstar Investment Services LLC with notifications on news.

Account

Morningstar Investment Services LLC Amgen Inc Transaction History